{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T05:29:57Z","timestamp":1648877397588},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,3]]},"DOI":"10.1093\/infdis\/jiaa560","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T16:45:24Z","timestamp":1612543524000},"page":"353-353","source":"Crossref","is-referenced-by-count":0,"title":["Erratum to: Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults \u226550 Years of Age"],"prefix":"10.1093","volume":"223","author":[{"given":"Roman","family":"Chlibek","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M","family":"Bayas","sequence":"additional","affiliation":[{"name":"Centro de Vacunaci\u00f3n de Adultos, Servicio de Medicina Preventiva y Epidemiolog\u00eda, Hospital Cl\u00ednic, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Collins","sequence":"additional","affiliation":[{"name":"Anderson & Collins Clinical Research, Inc, Edison, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa Rodriguez","family":"de la Pinta","sequence":"additional","affiliation":[{"name":"Occupational Risk Prevention Department, Puerta de Hierro Hospital, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Ledent","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Vaccines, Rixensart, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann F","family":"Mols","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Vaccines, Rixensart, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C","family":"Heineman","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Vaccines, King of Prussia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,20]]},"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/2\/353\/36183653\/jiaa560.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/2\/353\/36183653\/jiaa560.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T16:45:25Z","timestamp":1612543525000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/223\/2\/353\/5993994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,20]]},"published-print":{"date-parts":[[2021,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa560","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,15]]},"published":{"date-parts":[[2020,11,20]]}}}